HIV Diagnostic

An estimated 10 to 60 percent of individuals with early HIV infection will not experience symptoms. The exact proportion is difficult to estimate since patients generally seek medical attention because of symptoms, and thus asymptomatic infections often remain undetected.

An estimated 1.1 million persons in the United States have been infected with HIV; at the end of 2003, approximately 405,926 persons were living with AIDS. The number of reported cases in 2003 was essentially the same as the number in 1999. This trend follows a period of sharp decline in reported cases after the introduction of HAART (Highly Active Antiretroviral Therapy).
The tests to detect HIV are based on detecting either an antibody (our body own immune response) or an antigen( the virus or parts of the virus itself).

The standard third generation enzyme linked immunosorbent assays (ELISAs or immunoassays) used in clinical practice and in blood banks in the United States do not detect antibodies to Human immunodeficiency virus until three to seven weeks after symptoms.

Thus, depending on the time since infection and the sensitivity of the ELISA used, patients with acute Human immunodeficiency virus infection may have both a negative ELISA test and a negative Western Blot test or a positive ELISA with a negative or indeterminate Western Blot.

HIV RNA detection (Viral Load) — Early infection is characterized by markedly elevated Human immunodeficiency virus RNA levels or viral load, easily detectable with the HIV RNA (viral load) assays commonly used for monitoring of HIV disease.

Following infection, the time at which antibodies against Human immunodeficiency virus antigens can be detected in the serum depends upon the sensitivity of the serologic test as well as the person’s own immune system.



Leave a Comment

Your email address will not be published. Required fields are marked *

Contact Us

Give us a call at (855) 544-3258 or request a call below:

Laboratory Testing

1. Micronutrient Lab Testing
Overwhelming scientific evidence confirms that vitamin deficiencies are associated with disease processes and the overall condition of one’s health. Vitamin, mineral and antioxidant deficiencies have been shown to suppress immune function and contribute to chronic degenerative processes such as arthritis, cancer, Alzheimer’s, cardiovascular disease and diabetes. Using advance genetic testing this test will tailor any of your vitamin, minerals and or antioxidants needs. Based on a revolutionary method that measures the biochemical function of vitamins, minerals, amino acids and antioxidants, the micronutrient Lab Testing from Spectra Cell’s Laboratories provides a powerful portrait of each patient’s long-term nutrient status.
2. Cardiometabolic Risk Assessment/Lipoprotein Particle Profile Test
Approximately 50 percent of people suffering from heart attacks have shown “normal” cholesterol numbers. Cholesterol testing has historically been used as the standard indicator for cardiovascular disease classified as HDL (good) or LDL (bad). However, it is actually the lipoprotein particles that carry the cholesterol throughout our body, not necessarily the cholesterol within them, that are responsible for key steps in plaque production and the resulting development of cardiovascular disease. Now there is an advanced cholesterol testing technology, which accurately measures both the density and number of lipoprotein particles. This test allows us, with much better accuracy to determine the Risk of Coronary Artery Disease in our patients.